FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362491068> ?p ?o ?g. }

• W4362491068 abstract "<div>Abstract<p>Pretargeted radioimmunotherapy (PRIT) has been investigated as a multi-step approach to decrease relapse and toxicity for high-risk acute myeloid leukemia (AML). Relevant factors including endogenous biotin and immunogenicity, however, have limited the use of PRIT with an anti-CD45 antibody streptavidin conjugate and radiolabeled DOTA-biotin. To overcome these limitations we designed anti-murine and anti-human CD45 bispecific antibody constructs using 30F11 and BC8 antibodies, respectively, combined with an anti-yttrium (Y)-DOTA single-chain variable fragment (C825) to capture a radiolabeled ligand. The bispecific construct targeting human CD45 (BC8-Fc-C825) had high uptake in leukemia HEL xenografts [7.8 ± 0.02% percent injected dose/gram of tissue (% ID/g)]. Therapy studies showed that 70% of mice with HEL human xenografts treated with BC8-Fc-C825 followed by 44.4 MBq (1,200 μCi) of ⁹⁰Y-DOTA-biotin survived at least 170 days after therapy, while all nontreated controls required euthanasia because of tumor progression by day 32. High uptake at sites of leukemia (spleen and bone marrow) was also seen with 30F11-IgG1-C825 in a syngeneic disseminated SJL murine leukemia model (spleen, 9.0 ± 1.5% ID/g and bone marrow, 8.1 ± 1.2% ID/g), with minimal uptake in all other normal organs (<0.5% ID/g) at 24 hours after ⁹⁰Y-DOTA injections. SJL leukemia mice treated with the bispecific 30F11-IgG1-C825 and 29.6 MBq (800 μCi) of ⁹⁰Y-DOTA-biotin had a survival advantage compared with untreated leukemic mice (median, 43 vs. 30 days, respectively; <i>P</i> < 0.0001). These data suggest bispecific antibody–mediated PRIT may be highly effective for leukemia therapy and translation to human studies.</p></div>" @default.
• W4362491068 created "2023-04-05" @default.
• W4362491068 creator A5002822468 @default.
• W4362491068 creator A5004025497 @default.
• W4362491068 creator A5004062447 @default.
• W4362491068 creator A5005310150 @default.
• W4362491068 creator A5007024434 @default.
• W4362491068 creator A5023180146 @default.
• W4362491068 creator A5026348141 @default.
• W4362491068 creator A5036409687 @default.
• W4362491068 creator A5037938194 @default.
• W4362491068 creator A5040412322 @default.
• W4362491068 creator A5048283562 @default.
• W4362491068 creator A5053467199 @default.
• W4362491068 creator A5053638401 @default.
• W4362491068 creator A5059780147 @default.
• W4362491068 creator A5063615224 @default.
• W4362491068 creator A5076899086 @default.
• W4362491068 creator A5081797684 @default.
• W4362491068 creator A5084915025 @default.
• W4362491068 creator A5089439537 @default.
• W4362491068 creator A5090821183 @default.
• W4362491068 date "2023-04-03" @default.
• W4362491068 modified "2023-09-27" @default.
• W4362491068 title "Data from Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and ⁹⁰Y-DOTA" @default.
• W4362491068 doi "https://doi.org/10.1158/1535-7163.c.6542662" @default.
• W4362491068 hasPublicationYear "2023" @default.
• W4362491068 type Work @default.
• W4362491068 citedByCount "0" @default.
• W4362491068 crossrefType "posted-content" @default.
• W4362491068 hasAuthorship W4362491068A5002822468 @default.
• W4362491068 hasAuthorship W4362491068A5004025497 @default.
• W4362491068 hasAuthorship W4362491068A5004062447 @default.
• W4362491068 hasAuthorship W4362491068A5005310150 @default.
• W4362491068 hasAuthorship W4362491068A5007024434 @default.
• W4362491068 hasAuthorship W4362491068A5023180146 @default.
• W4362491068 hasAuthorship W4362491068A5026348141 @default.
• W4362491068 hasAuthorship W4362491068A5036409687 @default.
• W4362491068 hasAuthorship W4362491068A5037938194 @default.
• W4362491068 hasAuthorship W4362491068A5040412322 @default.
• W4362491068 hasAuthorship W4362491068A5048283562 @default.
• W4362491068 hasAuthorship W4362491068A5053467199 @default.
• W4362491068 hasAuthorship W4362491068A5053638401 @default.
• W4362491068 hasAuthorship W4362491068A5059780147 @default.
• W4362491068 hasAuthorship W4362491068A5063615224 @default.
• W4362491068 hasAuthorship W4362491068A5076899086 @default.
• W4362491068 hasAuthorship W4362491068A5081797684 @default.
• W4362491068 hasAuthorship W4362491068A5084915025 @default.
• W4362491068 hasAuthorship W4362491068A5089439537 @default.
• W4362491068 hasAuthorship W4362491068A5090821183 @default.
• W4362491068 hasBestOaLocation W43624910682 @default.
• W4362491068 hasConcept C150903083 @default.
• W4362491068 hasConcept C153911025 @default.
• W4362491068 hasConcept C159654299 @default.
• W4362491068 hasConcept C185592680 @default.
• W4362491068 hasConcept C203014093 @default.
• W4362491068 hasConcept C207001950 @default.
• W4362491068 hasConcept C2776146153 @default.
• W4362491068 hasConcept C2778461978 @default.
• W4362491068 hasConcept C2778729363 @default.
• W4362491068 hasConcept C2779931791 @default.
• W4362491068 hasConcept C2780007613 @default.
• W4362491068 hasConcept C2780868878 @default.
• W4362491068 hasConcept C2780931953 @default.
• W4362491068 hasConcept C502942594 @default.
• W4362491068 hasConcept C542903549 @default.
• W4362491068 hasConcept C71924100 @default.
• W4362491068 hasConcept C86803240 @default.
• W4362491068 hasConceptScore W4362491068C150903083 @default.
• W4362491068 hasConceptScore W4362491068C153911025 @default.
• W4362491068 hasConceptScore W4362491068C159654299 @default.
• W4362491068 hasConceptScore W4362491068C185592680 @default.
• W4362491068 hasConceptScore W4362491068C203014093 @default.
• W4362491068 hasConceptScore W4362491068C207001950 @default.
• W4362491068 hasConceptScore W4362491068C2776146153 @default.
• W4362491068 hasConceptScore W4362491068C2778461978 @default.
• W4362491068 hasConceptScore W4362491068C2778729363 @default.
• W4362491068 hasConceptScore W4362491068C2779931791 @default.
• W4362491068 hasConceptScore W4362491068C2780007613 @default.
• W4362491068 hasConceptScore W4362491068C2780868878 @default.
• W4362491068 hasConceptScore W4362491068C2780931953 @default.
• W4362491068 hasConceptScore W4362491068C502942594 @default.
• W4362491068 hasConceptScore W4362491068C542903549 @default.
• W4362491068 hasConceptScore W4362491068C71924100 @default.
• W4362491068 hasConceptScore W4362491068C86803240 @default.
• W4362491068 hasLocation W43624910681 @default.
• W4362491068 hasLocation W43624910682 @default.
• W4362491068 hasOpenAccess W4362491068 @default.
• W4362491068 hasPrimaryLocation W43624910681 @default.
• W4362491068 hasRelatedWork W1995037763 @default.
• W4362491068 hasRelatedWork W2001292827 @default.
• W4362491068 hasRelatedWork W2106180034 @default.
• W4362491068 hasRelatedWork W2369399909 @default.
• W4362491068 hasRelatedWork W2369624160 @default.
• W4362491068 hasRelatedWork W2387896437 @default.
• W4362491068 hasRelatedWork W2399213900 @default.
• W4362491068 hasRelatedWork W2909695583 @default.
• W4362491068 hasRelatedWork W3207807551 @default.
• W4362491068 hasRelatedWork W4366996634 @default.
• W4362491068 isParatext "false" @default.

• next